| |
|
|
|
|
Intellipharmaceutics Ltd.(TBA)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
|
| |
|
|
|
| Status: |
|
|
|
| |
| Address: |
405 Brittania Road, East, Suite 106,
|
FiledDate: |
|
| |
Mississauga,
|
|
|
| |
Ontario,
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
905-507-3001 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
21,247,446 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
21,247,446 |
| |
|
|
|
| Management: |
Isa Odidi, CEO
|
IPO Date: |
|
| |
|
|
|
| |
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
19 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 2003
|
0.00 |
761416 |
-761416 |
0.00 |
-881159 |
-0.08000000000000000166533453693773481063544750213623046875 |
| 2004
|
102332 |
1355063 |
-1252731 |
0.00 |
-1662352 |
-0.14000000000000001332267629550187848508358001708984375 |
| 2005
|
0.00 |
430619 |
-430619 |
0.00 |
-428158 |
-0.0299999999999999988897769753748434595763683319091796875 |
| *As of period Ended March 31, 2005
| |
|
|
Balance Sheet Data
|
Year |
Cash |
Acct Recv. |
Inventory |
Total Cur Assets |
Total Cur Liability |
PPE |
Total Assets |
LT Debt |
SH Equity |
|
2004 |
4250889 |
0.00 |
0.00 |
4592309 |
1927054 |
404124 |
4996433 |
0.00 |
-2639314 |
|
2005 |
3415343 |
0.00 |
0.00 |
3916050 |
1924732 |
616788 |
4532838 |
0.00 |
2608106 |
|
*As of period Ended March 31, 2005
| |
|
|
| Cash
Flow Summary
|
Year |
Net Cash-Ops |
Net Cash-Inv |
Net Cash-Fin |
Net Change |
|
2003 |
-588235 |
-114731 |
588371 |
-206200 |
|
2004 |
-1019426 |
-190175 |
5503641 |
4243703 |
|
2005 |
-553074 |
-245147 |
-10708 |
-835546 |
|
*As of period Ended March 31, 2005
| |
|
| |
|
| |
|
|
